Martin Janz Selected Research

Martin Janz Research Topics

Disease

8	Hodgkin Disease (Hodgkin's Disease) 10/2014 - 08/2003
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2021 - 12/2005
5	Neoplasms (Cancer) 07/2013 - 01/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022 - 04/2004
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 10/2020
3	Lymphoma (Lymphomas) 01/2022 - 05/2006
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2022
2	Multiple Myeloma 10/2009 - 05/2003
1	Infections 04/2021
1	Lung Diseases (Lung Disease) 04/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Carcinogenesis 12/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2017
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Primary Effusion Lymphoma 05/2007
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2005
1	Autoimmune Diseases (Autoimmune Disease) 01/2004
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2004
1	Acute Promyelocytic Leukemia 08/2003
1	Breast Neoplasms (Breast Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

5	Transcription Factors (Transcription Factor)IBA 12/2017 - 12/2005
3	BI 836826IBA 02/2021 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 02/2006 - 01/2002
2	Anaplastic Lymphoma KinaseIBA 10/2021 - 01/2021
2	Pyridinolcarbamate (P23)IBA 10/2021 - 04/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013 - 01/2004
2	NF-kappa B (NF-kB)IBA 12/2005 - 08/2003
1	Histone DemethylasesIBA 04/2022
1	Histones (Histone)IBA 04/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	ibrutinibIBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	GlucocorticoidsIBA 04/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018
1	ChromatinIBA 10/2014
1	Interferon Regulatory FactorsIBA 10/2014
1	TensinsIBA 07/2013
1	Sorafenib (BAY 43-9006)FDA Link 11/2011
1	Macrophage Colony-Stimulating FactorIBA 05/2010
1	Co-Repressor ProteinsIBA 05/2010
1	CCAAT-Enhancer-Binding Protein-betaIBA 10/2009
1	CytokinesIBA 10/2008
1	interleukin-21 (interleukin 21)IBA 10/2008
1	Basic Helix-Loop-Helix Transcription FactorsIBA 05/2007
1	PAX5 Transcription FactorIBA 05/2006
1	Activating Transcription Factor 3IBA 03/2006
1	pomalidomideIBA 05/2005
1	Thalidomide (Thalomid)FDA Link 05/2005
1	Death Domain ReceptorsIBA 04/2004
1	AntibodiesIBA 01/2004
1	AutoantigensIBA 01/2004
1	Immunoglobulin M (IgM)IBA 01/2004
1	anti-IgMIBA 01/2004
1	Pharmaceutical PreparationsIBA 08/2003
1	Arsenic Trioxide (Trisenox)FDA Link 08/2003
1	ArsenicIBA 08/2003
1	Chemokine CCL3IBA 05/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2002
1	Plasminogen Activator Inhibitor 1IBA 01/2002
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2002
1	Plasminogen InactivatorsIBA 01/2002
1	Biological FactorsIBA 01/2002

Therapy/Procedure

1	Therapeutics 01/2022
1	Breast Implants (Breast Implant) 01/2021
1	Drug Therapy (Chemotherapy) 01/2002